Carotid Artery Stenting: technology update

In the realm of stroke prevention, optimal medical therapy, encompassing antiplatelet agents, statins, blood pressure control, smoking cessation, and a healthy lifestyle, stands as a cornerstone in any revascularization strategy. Historical evidence underscores the significant benefit of carotid revascularization, particularly in symptomatic patients with severe carotid artery stenosis, positioning it as the standard of care alongside medical therapy. 

Guidelines advocate for prompt revascularization within 2 weeks of the event, with carotid artery stenting (CAS) emerging as a viable alternative to carotid endarterectomy. Extensive scientific scrutiny has underscored CAS's efficacy, particularly in asymptomatic patients, aiming for primary prevention.

CAS encompasses various stent designs, including open cell, closed cell, and dual-layered configurations. Studies suggest that stent designs with higher free cell areas may pose risks, especially in symptomatic patients, due to increased procedural and post-procedural complications. Advancements in technology have led to novel techniques and stent options, with operator experience and facility readiness playing pivotal roles in optimizing patient outcomes. Hospitals establish stringent credentialing criteria to ensure qualified operators and enhance procedural safety. With experience and randomized controlled trials involving thousands of patients, CAS has emerged as a reasonable and less invasive option for stroke prevention. Incorporating embolic protection devices and qualified operators further enhances procedural safety, with newer technologies promising continued improvement in outcomes.